Finance

Australia's Ramsay Health Care hits over 4-month low on steep drop in annual profit

Published by Global Banking & Finance Review

Posted on August 28, 2025

2 min read

· Last updated: January 22, 2026

Add as preferred source on Google
Spirax manufacturing facility showcasing growth in UK sales - Global Banking & Finance Review
Image of Spirax's manufacturing operations emphasizes the company's optimistic sales growth forecast for the second half of the year, reflecting strong performance in the finance sector.
Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) -Ramsay Health Care posted a steep drop in its annual results, hurt by a one-off charge and poor performance at its European division and British mental health service business, sending its

Ramsay Health Care Shares Plummet After Significant Annual Profit Decline

(Reuters) -Ramsay Health Care posted a steep drop in its annual results, hurt by a one-off charge and poor performance at its European division and British mental health service business, sending its shares to a more than four-month low.

The Australian private hospital operator posted a net profit after tax of A$24 million ($15.60 million) for the year ended June 30 on Thursday, compared with A$888.7 million a year ago.

That also missed the Visible Alpha consensus estimate of A$70.4 million.

Weaker results from Ramsay Santé, its European arm and Elysium, the British mental health business, higher net financing costs, among others, weighed on the firm's bottom line, the company said.

A one-off post-tax charge of A$291 million related to underperformance at Elysium further squeezed its earnings.

Santé, a private healthcare operator in Europe with its services spread across France, Italy, Norway, among others, has been underperforming for a while now.

Earlier this year, the company hinted at a potential sale of Santé and appointed Goldman Sachs to look at strategic options for its stake in the division.

"Ramsay remains committed to optimising shareholder returns and is reviewing a range of options (for Santé)," the hospital operator said on Thursday.

Shares of the firm dropped as much as 15.7% to A$32.1, as of 0214 GMT, hitting their record weakest session.

($1 = 1.5389 Australian dollars)

(Reporting by Rajasik Mukherjee; Editing by Alan Barona and Rashmi Aich)

Key Takeaways

  • Ramsay Health Care's annual profit dropped significantly.
  • Shares fell to a four-month low due to poor performance.
  • European and UK divisions underperformed, affecting earnings.
  • A one-off charge of A$291 million impacted results.
  • Strategic options for Ramsay Santé are under review.

Frequently Asked Questions

What was Ramsay Health Care's net profit after tax for the year?
Ramsay Health Care posted a net profit after tax of A$24 million for the year ended June 30.
What factors contributed to the decline in Ramsay's profit?
The decline was attributed to a one-off post-tax charge and poor performance from its European division and British mental health service business.
How much did Ramsay's shares drop following the profit announcement?
Shares of Ramsay Health Care dropped as much as 15.7% to A$32.1, marking their weakest session.
What strategic actions is Ramsay considering for its European division?
Ramsay has hinted at a potential sale of its European arm, Ramsay Santé, and has appointed Goldman Sachs to explore strategic options.
How did Ramsay's financial results compare to analyst expectations?
Ramsay's results missed the Visible Alpha consensus estimate of A$70.4 million, indicating a significant shortfall.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category